Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nippon Chemiphar: Drug Sales Fall 9.9% to \7,738 Mil.
December 15, 2003
- AnGes MG Begins PIII Study on HGF Gene Therapy Drug
December 15, 2003
- ICH-6 in Osaka Focuses on New Horizons and Future Challenges (2)
December 8, 2003
- Non-consolidated Sales of 29 Top Companies Down 0.3%
December 8, 2003
- REGULATORY NEWS IN BRIEF
December 8, 2003
- Alfresa Holdings: Fukujin, Azwell Show Mixed Results
December 8, 2003
- BULLETIN
December 8, 2003
- Astis: Consolidated Sales Down 2.1% at \43,756 Mil.
December 8, 2003
- Basic Policy on National Hospital Organization Issued
December 8, 2003
- Seiwa Sangyo: Consolidated Sales Rise 4.8% to \43.6 Bil.
December 8, 2003
- Nurse to Participate in Chuikyo as Expert Member
December 8, 2003
- Tsumura: Sales of Ethical Kampo Down 3.4%
December 8, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 8, 2003
- Zeria: Consumer Healthcare Brisk, but Ethical Sluggish
December 8, 2003
- Press Seminar
December 8, 2003
- SSP: Sales of OTC Products Down 4.8% to \23.8 Bil.
December 8, 2003
- Semi-annual Business Result
December 8, 2003
- Nikken Chemicals: 30%-decrease in Sales of Theodur Hurts Sales, Profits
December 8, 2003
- Sundrug: Sales, Ordinary Profits Up 16.5%, 3.8% Respecticely
December 8, 2003
- ON THE MOVE
December 8, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…